United Services Automobile Association’s CytomX Therapeutics CTMX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-134,001
Closed -$1.5M 729
2019
Q2
$1.5M Sell
134,001
-1,870
-1% -$19.6K ﹤0.01% 1181
2019
Q1
$1.46M Buy
135,871
+5,022
+4% +$74.2K ﹤0.01% 1177
2018
Q4
$1.98M Buy
130,849
+72,872
+126% +$1.08M 0.01% 1059
2018
Q3
$1.07M Buy
57,977
+5,527
+11% +$126K ﹤0.01% 1327
2018
Q2
$1.2M Sell
52,450
-1,411
-3% -$36K ﹤0.01% 1292
2018
Q1
$1.53M Buy
53,861
+25,261
+88% +$721K ﹤0.01% 1210
2017
Q4
$604K Buy
+28,600
New +$593K ﹤0.01% 1357

Other funds holding CTMX

United Services Automobile Association's CTMX Position: Q3 2019 in Review

United Services Automobile Association sold out of CytomX Therapeutics (CTMX) in Q3 2019, closing a stake of 134,001 shares — an estimated $1.5M sold.

United Services Automobile Association first reported a position in CTMX in Q4 2017 and held it in 7 quarters. The position peaked at $1.98M in Q4 2018. 113 funds tracked by Wall St. Rank hold CTMX as of Q3 2019.

  • United Services Automobile Association reported no remaining CytomX Therapeutics position as of Q3 2019 after selling out during the quarter.
  • United Services Automobile Association sold 134,001 CytomX Therapeutics shares in Q3 2019, an estimated $1.5M.
  • United Services Automobile Association first reported a position in CytomX Therapeutics in Q4 2017 and held it in 7 quarters.
  • United Services Automobile Association's CytomX Therapeutics position peaked at $1.98M in Q4 2018.
  • 113 funds tracked by Wall St. Rank held CytomX Therapeutics as of Q3 2019.

Based on United Services Automobile Association's 13F filing for Q3 2019, filed 13 Nov 2019.